Purpura of the Face and Neck: An Atypical Clinical Presentation Revealing a Hepatosplenic T Cell Lymphoma

Background: Hepatosplenic T cell lymphoma (HSTL) is a rare but very aggressive peripheral T cell lymphoma whose initial silent clinical presentation unfortunately delays the diagnosis and worsens the prognosis of patient survival. Efforts should be aimed at early recognition and treatment. Methods:...

Full description

Saved in:
Bibliographic Details
Main Authors: François Kuonen (Author), Maya Bucher (Author), Laurence de Leval (Author), Maxime Vernez (Author), Michel Gilliet (Author), Curdin Conrad (Author), Laurence Feldmeyer (Author)
Format: Book
Published: Karger Publishers, 2014-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_40a7d2d9d31044c8bb37008c1a937f9f
042 |a dc 
100 1 0 |a François Kuonen  |e author 
700 1 0 |a Maya Bucher  |e author 
700 1 0 |a Laurence de Leval  |e author 
700 1 0 |a Maxime Vernez  |e author 
700 1 0 |a Michel Gilliet  |e author 
700 1 0 |a Curdin Conrad  |e author 
700 1 0 |a Laurence Feldmeyer  |e author 
245 0 0 |a Purpura of the Face and Neck: An Atypical Clinical Presentation Revealing a Hepatosplenic T Cell Lymphoma 
260 |b Karger Publishers,   |c 2014-02-01T00:00:00Z. 
500 |a 1662-6567 
500 |a 10.1159/000360126 
520 |a Background: Hepatosplenic T cell lymphoma (HSTL) is a rare but very aggressive peripheral T cell lymphoma whose initial silent clinical presentation unfortunately delays the diagnosis and worsens the prognosis of patient survival. Efforts should be aimed at early recognition and treatment. Methods: We describe a case of a 62-year-old woman who presented at our clinic with a non-palpable purpuric eruption of the face. Investigations revealed thrombocytopenia with hepatosplenomegaly, which showed rapid progression together with accentuation of the purpura. Two months later, a bone marrow biopsy revealed the diagnosis of a HSTL. Results: The patient received six cycles of CHOP chemotherapy (vincristine, cyclophosphamide, doxorubicin, methylprednisolone) followed by a well-tolerated autologous bone marrow graft. Normalization of the platelet count resulted in regression of the purpuric rash. Conclusion: To our knowledge, this is the first report of a facial thrombocytopenic purpura as the inaugural symptom of HSTL. It emphasizes the privileged position of the dermatologist for early recognition of potentially lethal HSTL. 
546 |a EN 
690 |a Purpura 
690 |a Lymphoma 
690 |a Sun exposure 
690 |a Face 
690 |a Dermatology 
690 |a RL1-803 
655 7 |a article  |2 local 
786 0 |n Case Reports in Dermatology, Vol 6, Iss 1, Pp 37-42 (2014) 
787 0 |n http://www.karger.com/Article/FullText/360126 
787 0 |n https://doaj.org/toc/1662-6567 
856 4 1 |u https://doaj.org/article/40a7d2d9d31044c8bb37008c1a937f9f  |z Connect to this object online.